POSITIVE RESULTS FROM THE ALPINE 4 STUDY: A RANDOMIZED, DOUBLE- BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 2b TRIAL EVALUATING MULTIPLE DOSES OF THE FGF19 ANALOGUE ALDAFERMIN IN PATIENTS WITH COMPENSATED CIRRHOSIS DUE TO NONALCOHOLIC STEATOHEPATITIS

被引：0

作者：

Rinella, Mary ^{[1
]}

Lieu, Hsiao ^{[2
]}

Kowdley, Kris V. ^{[3
]}

Goodman, Zachary D. ^{[4
]}

Alkhouri, Naim ^{[5
]}

Lawitz, Eric ^{[6
]}

Ratziu, Vlad ^{[7
]}

Abdelmalek, Manal F. ^{[8
]}

Wong, Vincent Wai-Sun ^{[9
]}

Younes, Ziad ^{[10
]}

Ortiz-Lasanta, Grisell ^{[11
]}

Sheikh, Aasim ^{[12
]}

Brannan, Donald ^{[13
]}

Freilich, Bradley ^{[14
]}

Pianko, Stephen ^{[15
]}

Neff, Guy W. ^{[16
]}

Membreno, Fernando ^{[17
]}

Sinclair, Marie ^{[18
]}

Ankoma-Sey, Victor ^{[19
]}

Borg, Brian ^{[20
]}

Heneghan, Michael A. ^{[21
]}

LeMire, Marc ^{[22
]}

Schiefke, Ingolf ^{[23
]}

Thuluvath, Paul J. ^{[24
]}

Melchor-Khan, Liza ^{[25
]}

Anstee, Quentin M. ^{[26
]}

Tacke, Frank ^{[27
]}

Sanyal, Arun ^{[28
]}

Ling, Lei ^{[2
]}

Harrison, Stephen A. ^{[29
]}

机构：

[1] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA

[2] Univ Chicago Hosp, Chicago, IL 60637 USA

[3] Ngm Biopharmaceut, San Francisco, CA USA

[4] Washington State Univ, Pullman, WA 99164 USA

[5] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA

[6] Arizona Liver Hlth, Phoenix, AZ USA

[7] Univ Texas Hlth San Antonio, Texas Liver Inst, San Antonio, TX USA

[8] AP HP, Paris, France

[9] Mayo Clin, Rochester, MN USA

[10] Chinese Univ Hong Kong, Hong Kong, Peoples R China

[11] Gastro One, Cordova, TN USA

[12] FDI Clin Res, San Juan, PR USA

[13] GI Specialists Georgia, Marietta, GA USA

[14] Gastrointestinal Associates, Knoxville, TN USA

[15] Kansas City Res Inst, Kansas City, MO USA

[16] Monash Med Ctr, Clayton, Vic, Australia

[17] Tampa Gen Med Grp, Bradenton, FL USA

[18] Dhr Hlth Transplant Inst, Mcallen, TX USA

[19] Austin Hlth, Heidelberg, Vic, Australia

[20] Houston Methodist Hosp, Houston, TX USA

[21] Southern Therapy & Adv Res LLC, Jackson, MS USA

[22] Kings Coll Hosp London, London, England

[23] Royal Adelaide Hosp, Adelaide, SA, Australia

[24] Eugastro Gmbh, Leipzig, Germany

[25] Mercy Med Ctr, Baltimore, MD USA

[26] NGM Biopharmaceut Inc, San Francisco, CA USA

[27] Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, Newcastle Upon Tyne, Tyne & Wear, England

[28] Charite, Dept Gastroenterol & Hepatol, Berlin, Germany

[29] Virginia Commonwealth Univ, Div Gastroenterol Hepatol & Nutr, Richmond, VA USA

来源：

HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S12 / S16

页数：5

共 50 条

[1] TOPLINE RESULTS FROM THE ALPINE 2/3 STUDY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 2b TRIAL EVALUATING 3 DOSES OF THE FGF19 ANALOGUE ALDAFERMIN ON LIVER HISTOLOGY IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND STAGE 2 OR 3 FIBROSIS
Harrison, Stephen A.
Abdelmalek, Manal F.
Neff, Guy W.
Gunn, Nadege
Guy, Cynthia D.
Alkhouri, Naim
Bashir, Mustafa
Freilich, Bradley
Almeda, Jose
Knapple, Whitfield
Kohli, Anita
Khazanchi, Arun
Sheikh, Muhammad Y.
Leibowitz, Mark
Hogan, Reed
White, Judith
Kayali, Zeid
Rinella, Mary E.
Siddiqui, Mohammad S.
Kipnes, Mark
Moussa, Sam E.
Ortiz-Lasanta, Grisell
Poulos, John
Younes, Ziad
Bansal, Meena B.
Baum, Seth J.
Borg, Brian
Ruane, Peter J.
White, Alexander
Merkes, Kevin
Rashmee, Patil
Thuluvath, Paul J.
Gottwald, Mildred
Khan, Mujib
Chen, Charles
Yan, Andrew Z.
Melchor-Khan, Liza
Chang, William
DePaoli, Alex
Ling, Lei
Lieu, Hsiao
HEPATOLOGY, 2021, 74 : 5A - 6A
[2] Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis
Harrison, Stephen A.
Neff, Guy
Guy, Cynthia D.
Bashir, Mustafa R.
Paredes, Angelo H.
Frias, Juan P.
Younes, Ziad
Trotter, James F.
Gunn, Nadege T.
Moussa, Sam E.
Kohli, Anita
Nelson, Kristin
Gottwald, Mildred
Chang, William C. G.
Yan, Andrew Z.
DePaoli, Alex M.
Ling, Lei
Lieu, Hsiao D.
GASTROENTEROLOGY, 2021, 160 (01) : 219 - +
[3] EFFICACY AND SAFETY OF PEGBELFERMIN IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND COMPENSATED CIRRHOSIS: RESULTS FROM THE PHASE 2b, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED FALCON 2 STUDY
Abdelmalek, Manal F.
Sanyal, Arun J.
Nakajima, Atsushi
Neuschwander-Tetri, Brent A.
Goodman, Zachary
Lawitz, Eric J.
Harrison, Stephen A.
Jacobson, Ira M.
Imajo, Kento
Gunn, Nadege
Marzio, Dina Halegoua-De
Akahane, Takemi
Boone, Bradly
Yamaguchi, Masayuki
Chatterjee, Arkendu
Tirucherai, Giridhar S.
Shevell, Diane E.
Du, Shuyan
Charles, Edgar D.
Loomba, Rohit
HEPATOLOGY, 2021, 74 (06) : 1396A - 1397A
[4] Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
V. Ratziu
L. de Guevara
R. Safadi
F. Poordad
F. Fuster
J. Flores-Figueroa
M. Arrese
Anna L. Fracanzani
D. Ben Bashat
K. Lackner
T. Gorfine
S. Kadosh
R. Oren
M. Halperin
L. Hayardeny
R. Loomba
S. Friedman
Arun J. Sanyal
Nature Medicine, 2021, 27 : 1825 - 1835
[5] Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
Ratziu, V.
de Guevara, L.
Safadi, R.
Poordad, F.
Fuster, F.
Flores-Figueroa, J.
Arrese, M.
Fracanzani, Anna L.
Ben Bashat, D.
Lackner, K.
Gorfine, T.
Kadosh, S.
Oren, R.
Halperin, M.
Hayardeny, L.
Loomba, R.
Friedman, S.
Sanyal, Arun J.
NATURE MEDICINE, 2021, 27 (10) : 1825 - +
[6] Positive topline results from a 24-week, randomized, doubleblind, placebo-controlled, multicenter, phase 2 study of the FGF19 analogue aldafermin (NGM282) in patients with non-alcoholic steatohepatitis
Harrison, Stephen A.
Neff, Guy
Guy, Cynthia
Bashir, Mustafa
Paredes, Angelo
Frias, Juan
Younes, Ziad H.
Trotter, James F.
Gunn, Nadege T.
Moussa, Sam
Kohli, Anita
Nelson, Kristen
Gottwald, Mildred
Chang, William
Yan, Andrew
Depaoli, Alex
Ling, Lei
Lieu, Hsiao
JOURNAL OF HEPATOLOGY, 2020, 73 : S114 - S115
[7] Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial
Harrison, Stephen A.
Abdelmalek, Manal F.
Neff, Guy
Gunn, Nadege
Guy, Cynthia D.
Alkhouri, Naim
Bashir, Mustafa R.
Freilich, Bradley
Kohli, Anita
Khazanchi, Arun
Sheikh, Muhammad Y.
Leibowitz, Mark
Rinella, Mary E.
Siddiqui, Mohammad S.
Kipnes, Mark
Moussa, Sam E.
Younes, Ziad H.
Bansal, Meena
Baum, Seth J.
Borg, Brian
Ruane, Peter J.
Thuluvath, Paul J.
Gottwald, Mildred
Khan, Mujib
Chen, Charles
Melchor-Khan, Liza
Chang, William
DePaoli, Alex M.
Ling, Lei
Lieu, Hsiao D.
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (07): : 603 - 616
[8] EFRUXIFERMIN IN COMPENSATED CIRRHOSIS DUE TO NASH/MASH: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2b TRIAL (SYMMETRY)
Harrison, Stephen A.
Neff, Guy W.
Lucas, Kathryn Jean
Rodriguez, Manuel
Wofford, Scott
Benun, Jacques
Rudraraju, Madhavi
Noureddin, Mazen
Su, Yan
Chan, Doreen
Zari, Arian
De Temple, Brittany
Shringarpure, Reshma
Tillman, Erik
Rolph, Timothy P.
Cheng, Andrew
Yale, Kitty
HEPATOLOGY, 2024, 79 (02) : E37 - E39
[9] EFRUXIFERMIN (EFX) IN NONALCOHOLIC STEATOHEPATITIS WITH FIBROSIS: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2b TRIAL (HARMONY)
Harrison, Stephen A.
Frias, Juan P.
Neff, Guy W.
Abrams, Gary A.
Lucas, Kathryn Jean
Sanchez, William
Gogia, Sudhanshu
Sheikh, Muhammad Y.
Behling, Cynthia
Bedossa, Pierre
Shao, Lan
Fong, Erica
De Temple, Brittany
Shringarpure, Reshma
Tillman, Erik J.
Rolph, Timothy P.
Cheng, Andrew
Yale, Kitty
HEPATOLOGY, 2023, 77 (05) : E122 - E122
[10] Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial
Hirschfield, Gideon M.
Chazouilleres, Olivier
Drenth, Joost P.
Thorburn, Douglas
Harrison, Stephen A.
Landis, Charles S.
Mayo, Marlyn J.
Muir, Andrew J.
Trotter, James F.
Leeming, Diana J.
Karsdal, Morten A.
Jaros, Mark J.
Ling, Lei
Kim, Kathline H.
Rossi, Stephen J.
Somaratne, Ransi M.
DePaoli, Alex M.
Beuers, Ulrich
JOURNAL OF HEPATOLOGY, 2019, 70 (03) : 483 - 493

← 1 2 3 4 5 →